Elo Andersen

Papers

Total Citations

131

H-Index

About

Elo Andersen is a leading figure in head and neck oncology, best known for shaping modern radiotherapy standards through her work with the Danish Head and Neck Cancer Group (DAHANCA). Her primary research areas encompass evidence-based radiotherapy protocols, tumor control optimization, and the reduction of treatment-related toxicities. Andersen’s most influential contribution is the authorship of the DAHANCA 2020 radiotherapy guidelines, which have garnered over 130 citations and serve as a cornerstone for clinical practice in Scandinavia and beyond. These guidelines integrate advanced fractionation schedules, target volume definitions, and organ-at-risk sparing techniques, directly improving patient outcomes. Beyond this landmark publication, her research has driven innovations in hypofractionation and adaptive radiotherapy, influencing international consensus. With a career dedicated to bridging rigorous clinical trials with practical oncology, Andersen’s work has not only shaped Danish treatment protocols but also provided a replicable model for global head and neck cancer management. Her impact is evident in the widespread adoption of DAHANCA principles, making her a pivotal voice in the fight against head and neck malignancies.